Survival Rate of Chronic Obstructive Pulmonary Disease Patients with Type II Respiratory Failure at Haji Adam Malik Hospital
Authors
Abstract
Introduction: Chronic obstructive pulmonary disease is associated with acute exacerbations that can lead to respiratory failure and as major cause of morbidity and mortality worldwide. The Aim of study was to explore survival rate of COPD patients with type II respiratory failure
Methods: Observational research with retrospective cohort design using data from medical records of chronic obstructive pulmonary disease patients with type II respiratory failure treated at H. Adam Malik General Hospital Medan for 10 months from November 2021 to September 2022. Analyzed of independent and dependent variables used Chi Square test. To obtain most dominant independent variable that influence dependent variable, a multiple logistic regression test is used.
Results: There were 21 patients (50%) who alived until end of research but also 21 deaths occured. Survival rate was 50% with a median survival time 14 days (CI 95%: 7.178-20.822 days). Survival rate of COPD patients with type II respiratory failure who do not routinely received therapy was 16.7% with a median survival time 4 days (CI 95%: 42.962-5.039). Survival rate of COPD patients with type II respiratory failure who routinely received therapy was 75%. Based on log rank test, there was a significant difference median length of life between patients who did not and who routinely received therapy (p <0.001).
Conclusion: The survival rate in COPD patients who regularly use inhaler therapy is significantly higher than patients who do not routinely use inhaler therapy.
Similar Articles
- Cindy Giovanni, Nurita Dian Kestriani Saragi Sitio, Role of Intravenous Immunoglobulin (IVIG) in Patients with Guillain Barre Syndrome with Severe Community Pneumonia in The Intensive Care Unit (ICU) , Journal of Society Medicine: Vol. 3 No. 3 (2024): March
- Primta Bangun, Suwarman Suwarman, Weaning Difficulty in Patient with End Stage Renal Disease Acute with Respiratory Failure due to Pulmonary Edema and Pneumonia , Journal of Society Medicine: Vol. 2 No. 2 (2023): February
- Dadang Mulyawan, Osmond M. Pison, Management of Peripartum Cardiomyopathy in Severe Preeclampsia Patients in ICU , Journal of Society Medicine: Vol. 3 No. 2 (2024): February
- Batian Lubis, Dis Bima P Purwaamidjaja, Mayang Indah Lestari, Faisal, Muhammad Husni Thamrin, Febri Akhmad Belinda, A Case Series of Bleeding Complication Post Percutaneous Dilatational Tracheostomy and Management , Journal of Society Medicine: Vol. 2 No. 12 (2023): December
- Monica Tampubolon, Kiki M. Iqbal, R. A. Dwi Pujiastuti, Osmolarity Changes after Mannitol Administration in Cerebral Edema Patients , Journal of Society Medicine: Vol. 2 No. 7 (2023): July
- Sri Bayani, Amira Permatasari Tarigan, Pandiaman Pandia, Rina Amelia, Budi Jefri, The Effect of Providing Education on the Use of Inhalers on Asthma Degrees Based on the Asthma Control Test (ACT) in Patients at Tanjungpura Hospital , Journal of Society Medicine: Vol. 3 No. 10 (2024): Oktober
- Edlin, Mual Kristian Sinaga, Prolotherapy in Chronic Coccydynia , Journal of Society Medicine: Vol. 2 No. 2 (2023): February
- Nahrisyah Nahrisyah, Kristo A. Nababan, Reduction of 75% in the Psoriasis Area and Severity Index (PASI) for Moderate-to-Severe Psoriasis Vulgaris , Journal of Society Medicine: Vol. 4 No. 2 (2025): February
- Bramantyo Pamugar, Dhany Budipratama, Lung Protective Strategy in Acute Respiratory Distress Syndrome with Approach of Compliance and Mechanical Power , Journal of Society Medicine: Vol. 2 No. 10 (2023): October
- Nelly Rosdiana, Novia Kemal , Lactate Dehydrogenase and Blast Rates in the Diagnostic Phase and the Late Remission Phase of Acute Childhood Leukaemia Patients , Journal of Society Medicine: Vol. 3 No. 8 (2024): August
You may also start an advanced similarity search for this article.